tradingkey.logo
tradingkey.logo
Search

Labcorp Launches Molecular Residual Disease And Liquid Biopsy Solutions

ReutersApr 23, 2025 11:06 AM
facebooktwitterlinkedin
View all comments0

- Labcorp Holdings Inc LH.N:

  • LABCORP LAUNCHES MOLECULAR RESIDUAL DISEASE AND LIQUID BIOPSY SOLUTIONS

  • LABCORP HOLDINGS - PLASMA DETECT NOW AVAILABLE FOR CLINICAL USE TO ASSESS RISK OF RECURRENCE IN STAGE III COLON CANCER PATIENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI